XML 90 R77.htm IDEA: XBRL DOCUMENT v3.24.3
COMMITMENTS AND CONTINGENCIES - Narrative (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 06, 2022
USD ($)
payment
Mar. 31, 2025
USD ($)
Jun. 30, 2024
USD ($)
Sep. 30, 2024
USD ($)
liability
Sep. 30, 2023
USD ($)
Jan. 20, 2021
USD ($)
Jul. 29, 2019
USD ($)
Loss Contingencies [Line Items]              
Payment for contingent consideration       $ 11,923 $ 0    
Arkis              
Loss Contingencies [Line Items]              
Contingent consideration, estimated fair value             $ 25,500
Contingent consideration             13,100
Arkis | Development Milestones              
Loss Contingencies [Line Items]              
Contingent consideration, estimated fair value             10,000
Arkis | Commercial Sales Milestones              
Loss Contingencies [Line Items]              
Contingent consideration, estimated fair value             $ 15,500
Derma Sciences              
Loss Contingencies [Line Items]              
Number of contingent liabilities remaining | liability       1      
Contingent consideration, maximum undiscounted payment amount       $ 3,000      
Derma Sciences | BioD Earnout Payments and Medihoney Earnout Payments              
Loss Contingencies [Line Items]              
Payment for contingent consideration       $ 33,300      
ACell, Inc.              
Loss Contingencies [Line Items]              
Contingent consideration           $ 23,900  
Number of contingent liabilities remaining | liability       1      
Contingent consideration, maximum undiscounted payment amount           $ 100,000  
Surgical Innovation Associates, Inc.              
Loss Contingencies [Line Items]              
Contingent consideration, maximum undiscounted payment amount $ 90,000            
Number of contingent liabilities | payment 2            
Surgical Innovation Associates, Inc. | Revenue Based Performance Milestones              
Loss Contingencies [Line Items]              
Contingent consideration, estimated fair value $ 32,600            
Payment for contingent consideration     $ 12,400        
Contingent consideration, maximum undiscounted payment amount 50,000            
Surgical Innovation Associates, Inc. | FDA Approval Of Premarket Approval              
Loss Contingencies [Line Items]              
Contingent consideration, estimated fair value 25,000            
Contingent consideration, maximum undiscounted payment amount $ 40,000            
Plainsboro, New Jersey Manufacturing Facility | Forecast              
Loss Contingencies [Line Items]              
Purchase price of business acquisition   $ 10,000